Current status and future challenges of CAR-T cell therapy for osteosarcoma
Osteosarcoma, the most common bone malignancy in children and adolescents, poses considerable challenges in terms of prognosis, especially for patients with metastatic or recurrent disease. While surgical intervention and adjuvant chemotherapy have improved survival rates, limitations such as imprac...
Main Authors: | Shizhe Li, He Zhang, Guanning Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1290762/full |
Similar Items
-
Novel Immunotherapies for Osteosarcoma
by: Yubao Lu, et al.
Published: (2022-04-01) -
Current Status and Prospects of Immunotherapy for Osteosarcoma
by: WU Wei, et al.
Published: (2022-07-01) -
CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working
by: Zhu Y, et al.
Published: (2023-06-01) -
In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs
by: Zeyu Zheng, et al.
Published: (2024-01-01) -
Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
by: Yuna Jo, et al.
Published: (2020-07-01)